These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31955286)

  • 1. Differential Survival Impact of Diabetes Mellitus on Hepatocellular Carcinoma: Role of Staging Determinants.
    Ho SY; Yuan MH; Chen CC; Liu PH; Hsu CY; Huang YH; Lei HJ; Lee RC; Huo TI
    Dig Dis Sci; 2020 Nov; 65(11):3389-3402. PubMed ID: 31955286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.
    Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI
    Dig Dis Sci; 2020 Feb; 65(2):658-667. PubMed ID: 31659612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
    Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
    World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective.
    Su YW; Liu PH; Hsu CY; Lee YH; Hsia CY; Ho SY; Hou MC; Chen HS; Huo TI
    PLoS One; 2017; 12(3):e0174333. PubMed ID: 28333991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Adiponectin and Hepatocellular Carcinoma Survival Among Patients Without Liver Transplantation.
    Shen J; Yeh CC; Wang Q; Gurvich I; Siegel AB; Santella RM
    Anticancer Res; 2016 Oct; 36(10):5307-5314. PubMed ID: 27798893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma.
    Huo TI; Hsu CY; Huang YH; Hsia CY; Lin HC; Lee PC; Loong CC; Chiang JH; Chiou YY; Lee SD
    Liver Int; 2010 Feb; 30(2):198-207. PubMed ID: 19849777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score model.
    Hsu CY; Lee YH; Liu PH; Hsia CY; Huang YH; Lin HC; Chiou YY; Lee FY; Huo TI
    PLoS One; 2014; 9(2):e89373. PubMed ID: 24586728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
    Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival advantage of radiofrequency ablation over transarterial chemoembolization for patients with hepatocellular carcinoma and good performance status within the Milan criteria.
    Liu PH; Lee YH; Hsu CY; Huang YH; Chiou YY; Lin HC; Huo TI
    Ann Surg Oncol; 2014 Nov; 21(12):3835-43. PubMed ID: 24903236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system.
    Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Lin HC; Lee RC; Chiou YY; Lee FY; Huo TI
    Hepatology; 2013 Jan; 57(1):112-9. PubMed ID: 22806819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive therapeutic strategies improve the survival of hepatocellular carcinoma patients with performance status 1 or 2: a propensity score analysis.
    Hsu CY; Liu PH; Lee YH; Hsia CY; Huang YH; Chiou YY; Tsai YJ; Nagaria TS; Huo TI
    Ann Surg Oncol; 2015 Apr; 22(4):1324-31. PubMed ID: 25326394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma in uremic patients: is there evidence for an increased risk of mortality?
    Lee YH; Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Lee RC; Chiou YY; Huo TI
    J Gastroenterol Hepatol; 2013 Feb; 28(2):348-56. PubMed ID: 23190248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis in patients with hepatocellular carcinoma: Prevalence, determinants, prognostic impact and ability to improve the Barcelona Clinic Liver Cancer system.
    Hsu CY; Liu PH; Ho SY; Huang YH; Lee YH; Lee RC; Nagaria TS; Hou MC; Huo TI
    Liver Int; 2018 Oct; 38(10):1803-1811. PubMed ID: 29608816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma.
    Dhanasekaran R; Khanna V; Kooby DA; Spivey JR; Parekh S; Knechtle SJ; Carew JD; Kauh JS; Kim HS
    J Vasc Interv Radiol; 2010 Aug; 21(8):1197-204; quiz 204. PubMed ID: 20656222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
    Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
    Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Su CW; Lee FY; Lin HC; Huo TI
    Eur J Cancer; 2016 Aug; 63():25-33. PubMed ID: 27259100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
    Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
    World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus is associated with the presence of metastatic spread at disease presentation in hepatocellular carcinoma.
    Connolly GC; Safadjou S; Chen R; Nduaguba A; Dunne R; Khorana AA; Hezel AF
    Cancer Invest; 2012 Dec; 30(10):698-702. PubMed ID: 23072586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of diabetes mellitus in hepatocellular carcinoma patients after curative treatments: a meta-analysis.
    Wang WM; Xu Y; Yang XR; Wang YH; Sun HX; Fan J
    Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):346-55. PubMed ID: 21813381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy.
    Wang YY; Huang S; Zhong JH; Ke Y; Guo Z; Liu JQ; Ma L; Li H; Ou BN; Li LQ
    PLoS One; 2014; 9(12):e113858. PubMed ID: 25436613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.